Pluristem to Open Weekly Market Trading at TASE Following Positive Study Results
June 14 2018 - 07:00AM
Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading
developer of placenta-based cell therapy products, is delighted to
announce that it has been invited by the Tel Aviv Stock Exchange
(TASE) to open the weekly trading of the Israeli market, following
the announcement of its positive study results.
Pluristem recently announced positive top-line
results from its multinational Phase II clinical study of PLX-PAD
cells in the treatment of Intermittent Claudication, where
treatment was found to reduce the incidence of revascularization,
improve patients’ mobility and validate the design of the company’s
ongoing multinational Phase III study in Critical Limb
Ischemia.
The event will take place at the TASE on Sunday,
June 17, 2018 at 9:30am Israel time.
Pluristem welcomes its partners, investors and friends to join
the event.
Registration is required at:
Investor.relations@pluristem.com.
Contact:
Karine Kleinhaus, MD, MPHDivisional VP, North
America1-914-512-4109karinek@pluristem.com
Efrat KaduriHead of Investor and Public
Relations972-74-7108600efratk@pluristem.com
Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Pluristem Therapeutics (NASDAQ:PSTI)
Historical Stock Chart
From Mar 2023 to Mar 2024